Clinical Trials Directory

Trials / Sponsors / Nanjing Yoko Biomedical Co., Ltd.

Nanjing Yoko Biomedical Co., Ltd.

Industry · 9 registered clinical trials.

StatusTrialPhaseStarted
CompletedStudy on Tolerance, Pharmacokinetics and Drug Interaction of YK-1169 in Healthy Volunteers
Pharmacokinetics
Phase 12021-12-20
SuspendedStudy of Compound Edaravone Injection for Treatment of Acute Ischemic Stroke
Acute Ischemic Stroke
Phase 22021-11-15
UnknownSafety and Efficacy Study of Clevidipine Butyrate Injection in Hypertensive Emergencies
Hypertensive Emergency
Phase 32020-07-27
UnknownStudy on Clinical Effectiveness of L-Oxiracetam Injection
Craniocerebral Injury
Phase 32019-09-30
CompletedSafety, Tolerance and Pharmacokinetics Study of Compound Edaravone Injection
Pharmacokinetics
Phase 12019-06-05
CompletedDrug-drug Interaction Study Between Edaravone and 2-Aminoethanesulfonic Acid in Compound Edaravone Injection
Drug-drug Interaction
Phase 12019-05-10
UnknownA Study Comparing the Efficacy and Safety of G-CHOP Versus R-CHOP in Untreated Diffuse Large B-cell Lymphoma P
Diffuse Large B-Cell Lymphoma, Unspecified Site
Phase 32018-12-28
CompletedA Study Comparing GB241 And Rituximab in Patients With B-cell Non-Hodgkin's Lymphoma
B-Cell Lymphoma
Phase 12017-06-05
UnknownA Study of Tafetinib in Chinese Patients With Advanced Solid Tumor
Neoplasms
Phase 12015-05-01